Key result
A pharmacist-led intervention added to the Transitional Care Team decreased the 30-day readmission rate in high-risk heart failure patients from 33.7% to 21.3%.
Why the study?
To determine whether adding a pharmacist to the Transitional Care Team would decrease 30-day hospital readmissions in high-risk heart failure patients.
Does a pharmacist-led intervention added to a Transitional Care Team reduce 30-day hospital readmissions in high-risk heart failure patients?
Cohort
No
Does a pharmacist-led intervention added to a Transitional Care Team reduce 30-day hospital readmissions in high-risk heart failure patients?
Adding a pharmacist to a multidisciplinary transitional care team significantly reduces 30-day hospital readmissions and improves medication adherence in high-risk heart failure patients.
Answers are grounded in this paper and cite their sources.
May support pharmacist addition to HF transitional teams; leaves open confirmation via randomized trials.
Introduction Since the implementation of the Hospital Readmission Reduction Program, health systems have been working to reduce hospital readmission rates of patients with heart failure (HF). Of these efforts, the interventions with a multidisciplinary, multicomponent approach have lowered readmission rates as well as improved patient care, patient adherence, and patient outcomes. Objectives The primary objective of this study was to determine if the addition of a pharmacist to the Transitional Care Team (TCT) would decrease the number of high‐risk HF patients readmitted to the hospital before 30 days. Secondarily, this study assessed the change in self‐reported medication adherence. Methods This study was conducted at a community teaching hospital. A retrospective chart review was performed to identify HF patients who were at high risk for readmission admitted to the hospital from May 2012 to October 2013, as the historical control group. The intervention group included high‐risk patients with HF admitted from May 2014 to October 2015, who received the pharmacist‐led intervention during hospitalization and postdischarge. The pharmacist‐led intervention comprised five components: medication reconciliation, medication cost/formulary review, medication discharge counseling, providing and educating patients regarding self‐monitoring resources and postdischarge telephone follow‐up. The 8‐item Morisky Medication Adherence Scale was used to measure patients' self‐reported medication adherence at baseline, then 30 days after discharge. Results The pharmacist‐led intervention assisted in decreasing the readmission rate from 33.7% in the historical control group to 21.3% in the intervention group with a relative risk reduction of 0.696 (confidence interval: 0.488‐0.994). There was also a significant improvement in self‐reported patient medication adherence scores. Conclusion The addition of a pharmacist to the TCT that managed HF patients was associated with a decrease in the readmission rate for patients who were at high risk of readmission and improved self‐reported patient medication adherence.
No takes yet. Share an insight, caveat, or question.
Thurston et al. (2018) conducted a cohort in Heart failure. Pharmacist-led intervention vs. Historical control group was evaluated on Hospital readmission before 30 days (relative risk reduction 0.696, 95% CI 0.488-0.994). A pharmacist-led intervention added to the Transitional Care Team decreased the 30-day readmission rate in high-risk heart failure patients from 33.7% to 21.3%.
Synapse has enriched 10 related papers. Consider them for comparative context: